Showing results (61-70 of 3,878) with videos related to
Sort By:
Pageof 388
Journal of Cellular Physiology|April 6, 2019
The immune functions of PCSK9: Local and systemic perspectivesXing Liu, Rong Suo, Calista Zhuo Yi Chan, et al.Journal of Cardiovascular Development and Disease|February 24, 2023
Ticagrelor Can Regulate the Ion Channel Characteristics of Superior Cervical Ganglion Neurons after Myocardial InfarctionLijun Cheng, Lin Yu, Xiaoping Zhan, et al.Heart Rhythm|January 28, 2023
Radiotherapy-induced malfunctions of cardiac implantable electronic devices: A meta-analysisBeizheng Xu, Yueying Wang, Gary Tse, et al.Thrombosis Research|November 4, 2024
Co-administered oral anticoagulants with nonsteroidal anti-inflammatory drugs and the risk of bleeding: A systematic review and meta-analysisYi Zheng, Nan Zhang, Gary Tse, et al.Journal of Clinical Laboratory Analysis|January 10, 2018
Red blood cell distribution width as a predictor of atrial fibrillationQingmiao Shao, Panagiotis Korantzopoulos, Konstantinos P Letsas, et al.Clinical Cardiology|August 25, 2016
Meta-analysis of Vitamin D Deficiency and Risk of Atrial FibrillationZhiwei Zhang, Yajuan Yang, Chee Yuan Ng, et al.Pacing and Clinical Electrophysiology : PACE|March 13, 2016
Linear Ablation Following Pulmonary Vein Isolation in Patients with Atrial Fibrillation: A Meta-AnalysisZhiwei Zhang, Konstantinos P Letsas, Nixiao Zhang, et al.Cardiology Research and Practice|October 1, 2019
Effects of Trimetazidine Pretreatment on Endothelial Dysfunction and Myocardial Injury in Unstable Angina Patients Undergoing Percutaneous Coronary InterventionShuai Shao, Zhaozhao Shi, Gary Tse, et al.Molecular Medicine Reports|December 29, 2018
Ticagrelor suppresses oxidized low‑density lipoprotein‑induced endothelial cell apoptosis and alleviates atherosclerosis in ApoE‑/‑ mice via downregulation of PCSK9Xiaodong Xia, Jiao Li, Xue Liang, et al.Journal of Electrocardiology|May 7, 2020
Suppression of experimental atrial fibrillation in a canine model of rapid atrial pacing by the phosphodiesterase 3 inhibitor cilostazolZhiqiang Zhao, Ruiling Li, Xinghua Wang, et al.Pageof 388